[
  {
    "ts": "2026-01-07T08:53:34+00:00",
    "headline": "Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents",
    "summary": "Bayer's Monsanto unit filed patent infringement lawsuits Tuesday against COVID-19 vaccine makers Pfi",
    "url": "https://finance.yahoo.com/news/bayer-apos-monsanto-sues-pfizer-085334049.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "9fdc73e8-e2d5-3cd1-ae33-97a55643e795",
      "content": {
        "id": "9fdc73e8-e2d5-3cd1-ae33-97a55643e795",
        "contentType": "STORY",
        "title": "Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents",
        "description": "",
        "summary": "Bayer's Monsanto unit filed patent infringement lawsuits Tuesday against COVID-19 vaccine makers Pfi",
        "pubDate": "2026-01-07T08:53:34Z",
        "displayTime": "2026-01-07T08:53:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bayer-apos-monsanto-sues-pfizer-085334049.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bayer-apos-monsanto-sues-pfizer-085334049.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T10:07:16+00:00",
    "headline": "Update: Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents",
    "summary": "(Updates with BioNTech response in the sixth paragraph.) Bayer's Monsanto unit filed patent infri",
    "url": "https://finance.yahoo.com/news/bayer-apos-monsanto-sues-pfizer-100716677.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "775ea529-c935-3e25-afbf-8155fe883f52",
      "content": {
        "id": "775ea529-c935-3e25-afbf-8155fe883f52",
        "contentType": "STORY",
        "title": "Update: Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents",
        "description": "",
        "summary": "(Updates with BioNTech response in the sixth paragraph.) Bayer's Monsanto unit filed patent infri",
        "pubDate": "2026-01-07T10:07:16Z",
        "displayTime": "2026-01-07T10:07:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bayer-apos-monsanto-sues-pfizer-100716677.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bayer-apos-monsanto-sues-pfizer-100716677.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T13:33:00+00:00",
    "headline": "Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline",
    "summary": "AMGN's $840M buyout of Dark Blue Therapeutics adds a preclinical AML degrader, bolstering its oncology pipeline.",
    "url": "https://finance.yahoo.com/news/amgen-buys-dark-blue-therapeutics-133300371.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "64d7c3e3-e262-320d-ab36-8fc7a42a2056",
      "content": {
        "id": "64d7c3e3-e262-320d-ab36-8fc7a42a2056",
        "contentType": "STORY",
        "title": "Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline",
        "description": "",
        "summary": "AMGN's $840M buyout of Dark Blue Therapeutics adds a preclinical AML degrader, bolstering its oncology pipeline.",
        "pubDate": "2026-01-07T13:33:00Z",
        "displayTime": "2026-01-07T13:33:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/65410c79c0b8184da264ed17fda575ce",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tqYKNu6hTDA8V3302r2RBA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/65410c79c0b8184da264ed17fda575ce.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pyTd88a7yLXpjgTzs.cKAA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/65410c79c0b8184da264ed17fda575ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-buys-dark-blue-therapeutics-133300371.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-buys-dark-blue-therapeutics-133300371.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-07T18:10:02+00:00",
    "headline": "What BioNTech (BNTX)'s 90%+ COVID Vaccine Efficacy Signal Means For Shareholders",
    "summary": "Pfizer and BioNTech previously announced that their jointly developed COVID-19 vaccine showed over 90% effectiveness in preventing infection based on initial trial data, although scientists highlighted unanswered questions about long-term protection and impact on severe disease. This early efficacy signal positioned BioNTech’s mRNA platform at the center of the global pandemic response, while simultaneously underscoring the scientific and regulatory uncertainties that still surround...",
    "url": "https://finance.yahoo.com/news/biontech-bntx-90-covid-vaccine-181002470.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f0db17a9-003a-3447-b76e-f3080043c204",
      "content": {
        "id": "f0db17a9-003a-3447-b76e-f3080043c204",
        "contentType": "STORY",
        "title": "What BioNTech (BNTX)'s 90%+ COVID Vaccine Efficacy Signal Means For Shareholders",
        "description": "",
        "summary": "Pfizer and BioNTech previously announced that their jointly developed COVID-19 vaccine showed over 90% effectiveness in preventing infection based on initial trial data, although scientists highlighted unanswered questions about long-term protection and impact on severe disease. This early efficacy signal positioned BioNTech’s mRNA platform at the center of the global pandemic response, while simultaneously underscoring the scientific and regulatory uncertainties that still surround...",
        "pubDate": "2026-01-07T18:10:02Z",
        "displayTime": "2026-01-07T18:10:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I2k3PKJsWIEX9xgEQz8JwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tmSjpFKmBAT61w1lG5.BLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biontech-bntx-90-covid-vaccine-181002470.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biontech-bntx-90-covid-vaccine-181002470.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]